BioCentury | Apr 22, 2019
Distillery Therapeutics

Combined inhibition of EGFR and RAF1 for mutant-KRAS, mutant TP53-driven PDAC

...Ramon and Cajal Institute of Sanitary Research (IRYCIS), Madrid, Spain email: mcguerra@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Sandi Wong Ramon and Cajal Institute of Sanitary Research Spanish...
Items per page:
1 - 1 of 1
BioCentury | Apr 22, 2019
Distillery Therapeutics

Combined inhibition of EGFR and RAF1 for mutant-KRAS, mutant TP53-driven PDAC

...Ramon and Cajal Institute of Sanitary Research (IRYCIS), Madrid, Spain email: mcguerra@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Sandi Wong Ramon and Cajal Institute of Sanitary Research Spanish...
Items per page:
1 - 1 of 1